Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Groundhog Day For Byetta, GLP-1 Class: Is Regulatory Winter Nearly Over?

Feb 02 2009

• By Michael McCaughan

Related Content

The Next Bristol/ImClone? “Standstill” Provisions Complicate Other Deals

Sep 08 2008

FDA Review Of Byetta Monotherapy Heads Into 2009

Dec 08 2008

FDA’s Diabetes Guidance On CV Risk Will Get First Test With Pending NDAs

Dec 22 2008

Amylin Speculation Intensifies: Byetta LAR May Be Delayed

Nov 04 2008

Amylin Speculation Intensifies, Part 2: Activist Shareholders Grow Restless

Nov 04 2008

Miscommunicating Risk: The Byetta Disconnect

Aug 21 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window